These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7857215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT, Soares-Costa TJ, Gabriel HM.
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [My practice of thrombolysis in the acute phase of myocardial infarction in the light of extensive studies].
    Bory M.
    Ann Cardiol Angeiol (Paris); 1992 Dec; 41(10):595-7. PubMed ID: 1300923
    [Abstract] [Full Text] [Related]

  • 13. [Fibrinolytic treatment of myocardial infarction. Introduction].
    Kawecka-Jaszcz K.
    Przegl Lek; 1992 Dec; 49(9):310-11. PubMed ID: 1302357
    [No Abstract] [Full Text] [Related]

  • 14. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M.
    G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921
    [No Abstract] [Full Text] [Related]

  • 15. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L, Lüderitz B.
    Dtsch Med Wochenschr; 1996 Mar 29; 121(13):424. PubMed ID: 8681737
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations].
    Roguin A, Manaster J, Roguin N.
    Harefuah; 1993 Jun 15; 124(12):770-5. PubMed ID: 8375772
    [No Abstract] [Full Text] [Related]

  • 19. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP.
    J Clin Epidemiol; 2004 Aug 15; 57(8):843-52. PubMed ID: 15485737
    [Abstract] [Full Text] [Related]

  • 20. [The Medical Products Agency and thrombolytic therapy in acute myocardial infarction].
    Rasmussen K.
    Tidsskr Nor Laegeforen; 1994 Jun 30; 114(17):2033-4. PubMed ID: 8079341
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.